Background/Objectives: Folate and vitamin B12 have been suggested to play a role in chronic diseases like cardiovascular diseases. The objectives are to give an overview of the actual intake and status of folate and vitamin B12 in general populations in Europe, and to evaluate these in view of the current vitamin recommendations and the homocysteine concentration. Methods: Searches in Medline with 'folic acid', 'folate' and 'vitamin B12', 'B12' or 'cobalamin' as key words were combined with the names of the European countries. Populations between 18 and 65 years were included. Results: Sixty-three articles reporting on studies from 15 European countries were selected. Low folate intakes were observed in Norway, Sweden, Denmark and the Netherlands. Low intakes of vitamin B12 were not common and only seen in one small Greek study. In the countries with a low intake of folate, the recommended levels were generally not achieved, which was also reflected in the folate status. Vitamin B12 intake was not strongly associated with the vitamin B12 status, which can explain why in the Netherlands and Germany the vitamin B12 status was inadequate, despite sufficient intake levels. In countries with a low folate intake in particular, the Hcy concentration was higher than ideal. Conclusions: Populations from the Nordic countries, the Netherlands, Germany and Greece may need to improve their intakes of folic acid, B12 or both to either meet the recommendations or to optimize their statuses. This could be achieved via a foodbased approach, food fortification or supplements.
Introduction
Much attention has been given to B-vitamins, in particular to folate and vitamin B12, because of their potential influence on cardiovascular diseases (CVD) (Folsom et al., 1998; Rimm et al., 1998; Eikelboom et al., 1999; Chambers et al., 2001; Schnyder et al., 2001; Voutilainen et al., 2001 Voutilainen et al., , 2004 , cognitive function Malouf et al., 2003; Tucker et al., 2005) and bone health (McLean et al., 2004; van Meurs et al., 2004; Sato et al., 2005) . The link between these B-vitamins and CVD is suggested to be, partly, explained via homocysteine (Hcy), though conclusive trial evidence of lowering Hcy is still required to have sufficient power to detect plausible differences in risk at convincing levels of significance (Anonymous, 2006) .
Folate is present in a wide range of foods such as vegetables, bread, dairy products, liver and fruits. Folic acid is the synthetic form of folate present in supplements and in fortified foods. Foods rich in vitamin B12 are dairy products, meat, liver, fish, eggs and shellfish. Supplementation with folic acid and vitamin B12 can reduce Hcy concentrations by approximately 32% in the general population (Anonymous, 2005; Verhoef and de Groot, 2005) .
The important role that folate and vitamin B12 could play in health maintenance has triggered our interest in the adequacy of the status of these B vitamins. We evaluated (1) the actual dietary intake of folate and vitamin B12 and (2) the actual folate, vitamin B12 and Hcy status in European populations, taking into account the recommended intakes and the association with Hcy.
Methods
Literature search A computerized MEDLINE search, from January 1990 through December 2005, was used to identify (English) papers that reported on folate or vitamin B12 intake or status in general population-based samples. The key words 'folic acid', 'folate' and 'vitamin B12', 'B12' or 'cobalamin' were combined with the names of the European countries in the search. As our main interest was the intake and status of folate and vitamin B12, we did not include a search term for 'homocysteine'. We included Hcy status only when data on Hcy status were available in the identified articles. In addition, we checked reference lists for additional relevant studies. Authors were approached in case we were not able to obtain their articles (n ¼ 12).
Study populations
Articles dealing with European populations older than or equal to 18 years, and younger than or equal to 65 years were included. A few exceptions were made when studies concerned broader age groups (for example, 25-74 years). Only studies containing data of more than 100 apparently healthy adults (men or women) were included. For casecontrol studies (such as cancer studies), only data from control groups were used. Studies focussing on pregnant or lactating women or on people from non-European origin (because of their different dietary pattern) were not included. Studies that a priori divided subjects by specific characteristics such as smoking status or genetic polymorphisms were not included. Finally, when a paper did not clearly define the study group, it was not included.
Assessment of dietary intake and status
No specific selection criteria were used regarding the assessment methods to select the papers of interest. Thus, different dietary methods are reported in this paper, including dietary records (2, 3, 4 or 7 days), 24 h recalls, dietary histories and food frequency questionnaires. In principle, data on B-vitamin intake originating from the diet itself are shown, and not from supplements. When the method of dietary assessment was not clearly described, the study was not included. Several studies did not provide information on the method used for determination of folate and vitamin B12 in the food composition tables.
Most studies determined folate and vitamin B12 status by radio(immuno)assay, by IMx or by using microbiological assays on microtitre plates with a chloramphenicol-resistant strain of Lactobacillus casei and a colistin sulphate-resistant strain of Lactobacillus leichmanni, for folate and vitamin B12 respectively. When the microbiological method was used, this is indicated in the footnote of the related (Table 2) in 15 European countries. Twenty-nine articles from 12 countries were identified, which provided information on intake of folate and/or vitamin B12. Thirty articles from 13 countries provided information on status of folate and/or vitamin B12. Only 10 articles reported on both intake and status.
Several articles reported on the same study populations; articles providing the least information were excluded from this review.
Results

Intake of folate
Average folate intake ranged from 205 to 431 mg day À1 in the diet of men and from 186 to 465 mg day À1 in women (Table 1 ).
The range of mean folate intake in the studies that combined the intake of men and women was smaller: 190-290 mg day
À1
(eight studies). In general, men had a higher mean folate intake than women within studies. Based on data of Schroder et al. (2004) , it could be postulated that men and women have more similar intake levels when intakes are adjusted for energy intake.
No clear North-South gradient in the intakes of folate was observed across Europe. Most favourable intakes (4350 mg day
) were observed in two study populations in the United Kingdom (Kirk et al., 1999; Davey et al., 2003; Cade et al., 2004) . Moderate folate intakes (250-350 mg day À1 ) were observed in Finland, Ireland, Germany, France, Italy, Spain (except for the study of Planells et al., 2003) and Greece. Low intakes (o250 mg day À1 ) were observed in Norway, Sweden, Denmark, The Netherlands and in one Spanish study (Planells et al., 2003) . Similar to folate, within studies men tended to have a higher vitamin B12 intake than women. Although no clear North-South gradient in the intakes of vitamin B12 can be observed in the European countries, the highest intakes of vitamin B12 were observed consistently in three Finnish studies and the lowest intake of vitamin B12 (o2.5 mg day
) was found in Greece (Vrentzos et al., 2004) . In Sweden, Germany, France and Spain the mean vitamin B12 intake was high (45 mg day À1 ) as well. Note however, that in Sweden and France only one study was available.
Countries with moderate-to-high (2.5-5 mg day
) intakes were Denmark, Ireland and The Netherlands. The populations in the United Kingdom had a large variance in vitamin B12 intake which was mainly due to the type of diet; vitamin B12 intake decreased by following a more vegetarian diet. Overall, the English had a moderate-to-high vitamin B12 intake.
Meeting the national recommendations?
Within Europe, different recommendations defined as recommended daily allowances or adequate intakes, exist for folate and vitamin B12 intake (Table 2) . Recommendations vary between 200 and 400 mg day À1 for folate and between 1.4 and 3.0 mg day À1 for vitamin B12 (SCF, 2003) .
In Finland, the United Kingdom, Ireland, France, Italy, Spain and Greece, study populations had a mean folate intake at or above their respective national recommendations. In Norway, Sweden, Denmark, Netherlands and Germany, mean folate intake levels were lower than the recommendations. It is important to notice that even when the population mean intake equals the recommended intake, this still means that many (in case of a normal distribution: 50%) people do not achieve the recommended intake level.
Vitamin B12 intake was above the country-specific recommendations for all countries, except for the Greek population and the vegetarians in the United Kingdom.
Status of folate, vitamin B12 and homocysteine
Folate status ranged from 6.3 to 20.1 nmol l À1 (Table 3) ). Finally, a marginal average vitamin B12 status (o300 pmol l À1 ) occurred in study populations from the Netherlands, Germany, in one Czech study (Vesela et al., 2005) and in one Italian study (Sofi et al., 2005) . Homocysteine levels differed to a great extent between countries: from 7.1 to 14.8 mmol l À1 . Overall, Hcy levels were consistently higher in men than in women within the same studies. Fasting plasma Hcy concentrations below 15 mmol l À1 are generally regarded as 'normal', whereas concentrations above 15 mmol l À1 are considered as 'elevated' . Concentrations below 10 mmol l À1 are seen as 'ideal'. Only two countries presented an ideal average Hcy concentration: Ireland and Portugal, but only one study was available for each country (Brown et al., 2003; Castro et al., 2003) . Other populations with Hcy concentrations close to 10 mmol l À1 were Norway, the United Kingdom, Germany, Czech Republic, France and Spain. In Finland and Italy, Hcy concentration varied greatly. The higher Hcy concentration in the Finnish ATBC study was because the cohort consisted of male smokers (Hartman et al., 2001) . The highest Hcy concentrations, close to 15 mmol l
À1
, were seen in the Netherlands and Sweden.
Intake reflected in status
We examined whether intake of folate and vitamin B12 is reflected in its status (Table 4) . Folate intake was repeatedly Dietary intake and status of folate and vitamin B12 in European populations RAM Dhonukshe-Rutten et al An inverse association between folate status and Hcy levels was consistently reported in the majority of the studies. The correlations varied between À0.23 and À0.56. Also, Mennen et al. (2002) and Sofi et al. (2005) , observed significant associations within their trend analysis (Po0.0001).
Rarely, vitamin B12 intake was strongly correlated with vitamin B12 status. Sofi et al. (2005) did not observe significant associations between vitamin B12 intake and Hcy status in their linear regression analysis. In none of the studies the correlation of vitamin B12 intake with Hcy status was assessed. de Bree et al. (2001a) performed a P-test for trend: Hcy status was inversely associated with vitamin B12 intake per quintile (Po0.001).
Vitamin B12 correlated consistently and significantly inversely with Hcy; with correlations between À0.16 and À0.49. Also Mennen et al. (2002) and Sofi et al. (2005) observed associations within their trend analysis (respectively P ¼ 0.06 and 0.01).
Discussion
Main findings
We reviewed intakes and status of folate, vitamin B12 and Hcy in general populations (p65 years) from 15 European countries to evaluate whether intake and status of these B-vitamins is adequate. Inadequate folate intakes were seen in Norway, Sweden, Denmark and Netherlands; intakes were below 250 mg day À1 and for Netherlands even below 200 mg day
À1
. Not surprisingly, the national recommendations for folate were not achieved in these countries. This was also the case with Germany, but the recommendation in this country is set at a higher level, that is 400 vs 300 mg day À1 in Norway, Sweden, Denmark and Netherlands.
The low folate intake levels were reflected in a low folate status within the same study populations (de Bree et al., 2001a (de Bree et al., , 2003a Brevik et al., 2005; Van Guelpen et al., 2005) . However, studies with data on folate status but not on intake, supported the notion that folate status in the abovementioned countries was low (Nurk et al., 2004; Hultdin et al., 2005) . As a result, the Hcy levels in the Netherlands and Sweden were also relatively high. The intake of vitamin B12 was in general adequate, with the exceptions of intake in British vegans (Davey et al., 2003) and in a small Greek study population (Vrentzos et al., 2004) . Yet the Greek did not have an inadequately low vitamin B12 status. Likewise, the mean intake level of vitamin B12 in the Netherlands and Germany lay far above the recommended level; nevertheless, the vitamin B12 status in these countries was inadequate. The absence of a clear cut relation between vitamin B12 intake and status is also illustrated by the data in Table 4 . The relatively low vitamin B12 status in Dutch subjects could also have contributed to the somewhat higher Hcy concentrations in this country. Reasons for no association of vitamin B12 intake and status have to do with the many causes of vitamin B12 malabsorption. Malabsorption is mainly present in elderly people (Baik and Russell, 1999) . Moreover, because vitamin B12 is the best stored of all vitamins, with enough stores to last 3-5 years in a normal replete subject, there is no association between its intake and status in adults. Dietary intake and status of folate and vitamin B12 in European populations RAM Dhonukshe-Rutten et al Differences within countries are partly explained by the fact that some populations consisted solely of women (for example, Roddam et al., 2005) and others solely of men (for example, Wilmink et al., 2004) . Men had in general a higher intake of folate and vitamin B12 than women, an effect that is probably reduced when corrections for energy intake are applied (Schroder et al., 2004) . Explaining differences between countries remains speculative, but is probably mainly due to the type of diet. This is clearly illustrated in a British study where meat-eaters had lower intakes of folate than vegetarians and vegans (Davey et al., 2003) . Another study in the United Kingdom also showed slightly higher intakes of folate in vegetarians and fish-eaters than in meateaters. Considering vitamin B12, the opposite occurred with lower vitamin B12 intakes in fish-eaters, vegetarians and vegans as compared to meat-eaters (Cade et al., 2004) .
Value of these intake data When intake figures are compared between countries, it should be realized that methodological differences between studies are a source of variation in folate intake. The several methods used to collect dietary information have their own advantages and disadvantages, which can potentially have led to an over-or underestimation of the habitual intake (McNulty, 1995) . Moreover, the nutrient databases could differ from each other. The low folate and vitamin B12 intake observed in some study populations could be due to a genuine low intake or to a nutrient database which has lower values for folate and vitamin B12 contents in food products (because of different analysis methods) than databases in other countries.
Furthermore, data based on long-term habitual consumption provide more stable intake estimates than data based on short-term intake (Cameron and Van Staveren, 1988) . Only a few studies in this review estimated the dietary intake with a single 24-h dietary record. When we compare these dietary intakes with the other studies within the same country, the intakes seem to be similar.
Judging adequacy
While comparing intakes with national and international recommendations, we have to be aware that recommendations are calculated to be sufficient to meet the basic nutrient requirements of nearly all individuals in the group (mean þ 2 s.d.). The recommendations are not set to achieve optimal health effects, for this goal, higher levels may be required. Currently, the labelling reference value for folate, as set by the Scientific Committee on Food, is 200 mg day
À1
. Only Italy, Spain and Greece agree with this level. All other countries use a recommended level of 300 or even 400 mg day À1 . Presently, folate recommendations are under debate in several European countries partly because higher intakes might be required to obtain low Hcy concentrations. For example, a meta-analysis showed that folic acid of X800 mg day À1 is typically required to achieve the maximal reduction in plasma Hcy concentrations (Anonymous, 2005) . Daily doses of 400 mg day À1 are associated with 90% of the maximum reduction in blood Hcy concentrations (van Oort et al., 2003; Anonymous, 2005) . Also vitamin B12 recommendations are re-evaluated for a potential adjustment towards a higher level, especially for elderly (465 years), as deficiencies mainly occur in this group (Baik and Russell, 1999) . Although this age group was beyond the scope of this article, it is illustrative that doses 4200 times greater than the recommended dietary allowance are required to obtain a normal vitamin B12 status in elderly people (Eussen et al., 2005) . These high doses, which ensure passive absorption (in humans), might be required for elderly with (mild) vitamin B12 deficiency or with absorption problems and are attainable with supplements rather than with food (such as meat and dairy products). It is less certain whether such high doses are also required for a general adult population, as Bor et al. (2006) showed that a daily intake of 6 mg was sufficient to normalize all vitamin B12-related variables in 98 Danish postmenopausal women.
Extrapolations
It is important to discuss to what extent these data can be generalized to the 'European population'. First, for this inventory, as many studies as possible were identified that contained relevant data. We did not include data of large national surveys because these surveys in general do not have data on biochemical markers of intake, which would complicate relating intake data to status data within a country. We are aware that there is probably more information available on folate and vitamin B12 data in the original language of the European countries. The question remains whether this information has the same quality (which was one of the criteria for the articles to be included in this review) as articles published in scientific, English-written, peer-reviewed journals. Moreover, the articles we reviewed are accessible for everybody. Second, despite our efforts, the final number of included studies was 63 of which only 13 studies contained information on both intake and status. Third, we collected information from general, apparently healthy study populations and from control groups in cohort or case-control studies. Especially, the latter group makes it more complicated to be able to generalize our findings. Moreover, the selection of a general population, existing of volunteers, could have led to an inclusion of a more healthy population because volunteers generally follow a more favourable lifestyle profile (Verschuren et al., 1993) . Furthermore, we selected studies with study samples of larger than 100 people. This number of subjects is arbritary and therefore it remains questionable whether some of the included studies are indeed too small to represent a certain country. Therefore we should be genuinely cautious and may rely more on the national food composition surveys mainly published in the original language of the countries. Using a true random sample of the European population would almost certainly result in higher prevalence of low folate and vitamin B12 intake and status, and high Hcy status. Fourth, an important problem with estimating the folate and vitamin B12 intake is the lack and unreliability of the folate and vitamin B12 content data in food composition tables. This problem can lead to an underestimation of the actual intake (Black et al., 1985) . Finally, differences exist not only between laboratories but also between methods used for determination of folate, vitamin B12 and Hcy status. As described in the Methods section, three methods were used for determination of folate and vitamin B12 concentrations. Bolann et al. (2000) did not find a significant bias for serum cobalamin values, so cobalamin values from different studies can readily be compared with each other. The judgment of cobalamin status remains however controversial because for example, a 'low' cobalamin value may not represent a metabolic-deficient cobalamin status. Therefore, it would be better to judge cobalamin concentrations in combination with elevated methylmalonic acid and/or Hcy concentrations (Klee, 2000) . For folate, the IMx method gave 6% higher results than the radioassay method. Two methods were used for determination of Hcy concentrations. These differences in method are known to influence the measurement of Hcy levels (Pfeiffer et al., 2000; Caliskan et al., 2001; Zappacosta et al., 2002) . Moreover, serum yields slightly higher Hcy values than plasma, while optimally collected ethylenediaminetetraacetic acid or heparin plasma gives identical results and citrated plasma yields lower Hcy values .
We did not observe a North-South gradient in intake or status of folate, vitamin B12 and Hcy, while de Bree et al. (1997) , who studied folate intake in national food consumption surveys, observed a North-South gradient with lower folate intakes in the Northern countries. Differences in folate intake may have partly reflected differences in dietary habits among European countries, with the Mediterranean diet providing more folate-rich foods. The national food consumption surveys may better reflect the dietary habits across European countries than the studies we included in this review.
Folate, vitamin B12, homocysteine and cardiovascular diseases Folate, vitamin B12 and Hcy are believed to play a role in the development of CVD. Cohort and case-cohort studies suggest that low intake and low levels of serum or erythrocyte folate, independent of Hcy concentrations, are associated with vascular disease morbidity and mortality. Data from several but not all prospective studies showed a reduced risk of CVD and stroke associated with high folate intake or blood concentrations (see for an overview Eikelboom et al., 1999; Schwammenthal and Tanne, 2004) .
A meta-analysis has found that a 2.6 mmol l À1 higher Hcy was associated with a 13% (95% CI 8-19%) increase in risk of CVD (Anonymous, 2002) . However, recently some doubt has been raised on the effectiveness of folate and vitamin B12 supplementation on CVD as outcome measure. The first results came from the Vitamin Intervention for Stroke Prevention (VISP) trial (Toole et al., 2004) , the Norwegian Vitamin trial (NORVIT) (Bonaa et al., 2006) and the Heart Outcomes Prevention Evaluation 2 study (HOPE) (Lonn et al., 2006) . Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major (recurrent) vascular outcomes in patients with (cardio)vascular disease. In the NORVIT trial, folic acid and vitamin B12 treatment was even associated with a nonsignificant increase in risk of recurrent myocardial infarction, stroke or sudden death. Positive findings were observed in a subgroup of patients in the VISP trial. In these patients, who were not already taking B12 supplements and not having B12 malabsorption or renal failure, survival was improved (Spence et al., 2005) . Also in the HOPE-2 trial, fewer incidents of stroke occurred in the treatment group compared to the placebo group. Nevertheless, these studies have been performed in patients, and therefore conclusions cannot be generalized to the healthy population. The strength of association of Hcy with risk of CVD may be weaker than had previously been believed (2006) . Examining the studies included in this review, only 10 studies reported on associations of folate, vitamin B12 and Hcy with CVDs (Verhoef et al., 1997; Girelli et al., 1998 Girelli et al., , 2003 Christensen et al., 1999; Chambers et al., 2000; de Bree et al., 2003b; Nurk et al., 2004; Voutilainen et al., 2004; Vrentzos et al., 2004; Durga et al., 2005; Van Guelpen et al., 2005) . Homocysteine status was positively associated with several outcome measures of CVD in 8 out of 10 studies. Folate and vitamin B12 were less often investigated in association to CVD, respectively in six and three studies. The findings were not consistent but tended to go into the direction of an inverse association of folate intake or status with CVD and no association of vitamin B12 intake or status with CVD.
What can be done about low intake/status? As indicated in this review, several European countries do not have adequate folate and vitamin B12 intakes with respect to the recommendations, and also with respect to the status of these B-vitamins and Hcy concentration. To achieve health benefits, intakes should probably be higher than the recommendations. Several approaches to increase the intake of folate and vitamin B12 are possible (Finglas et al., 2006) ; (a) a food-based approach which includes a healthy lifestyle consisting of a diet rich in green leafy vegetables (rich in folate and betaine), meat and dairy products (rich in vitamin B12), together with a moderate coffee and protein intake. It should also be emphasized to select foods with high folate content and advice should be given which household preparation method can be used (McKillop et al., 2002) . Different processing treatments can influence the bioaccessibility of folate from vegetables. Freezing and high-pressure treatments are promising approaches for improving the Dietary intake and status of folate and vitamin B12 in European populations RAM Dhonukshe-Rutten et al bioaccessibility of folate from vegetables. (b) Consumption of food products rich in folate and vitamin B12 or by food fortification. Different types of food fortification exist: (1) biofortification by traditional breeding methods or genetic modification; and (2) food fortification by industry in processed food products; and (3) processing methods to increase the amount of bioavailable folate in vegetables. (c) Supplementation with folate and vitamin B12 capsules. Especially, at old age, this is less preferable due to the high number of capsules often taken by elderly people (Ryan, 1999) . (d) Introduction of mandatory fortification of certain foods with folate and vitamin B12. Especially people who are not aware that their diet is inadequate or who do not have the knowledge to improve their diet, might benefit from foods fortified with folate (Eichholzer et al., 2006) . National regulations for voluntary or mandatory fortification of foods intended for general consumption still vary greatly in Europe. With mandatory fortification (like in the US and Canada) to prevent neural tube defects in unborn babies, a decision is made for an entire population without asking for individual informed consent. Safety issues of folic acid fortification, such as masking of symptoms of vitamin B12 deficiency (Committee on Aspects of Food Policy, 2000; Food Standards Agency, 2002), interactions with drugs, hypersensitivity reactions, cancer promotion and increase of twinning rate (Campbell, 1996; Eichholzer et al., 2002) need to be taken into account in this policy decision. Moreover, additional health effects on top of the prevention of Neural tube defects, like a reduced risk of CVD, are not yet conclusively proven.
Conclusion
Low folate intakes were observed in Norway, Sweden, Denmark and Netherlands. Low intakes of vitamin B12 were not common and seen only in one small Greek study. In countries with a low intake of folate, the recommended levels were generally not achieved, which was also reflected in folate status. Vitamin B12 intake was not strongly associated with vitamin B12 status, which can explain why in the Netherlands and Germany the vitamin B12 status was inadequate, despite sufficient intake levels. In countries with a low folate intake, the Hcy concentration was higher than ideal. Populations in these countries may need to improve their intakes of FA and B12 to either meet the recommendations or to optimize their statuses. An increased intake could be achieved via a food-based approach, food fortification or supplements.
